Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

20 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/20/3192053/0/en/RespireRx-Pharmaceuticals-Inc-CFO-and-CEO-Issue-Letter-to-Stockholders-Stakeholders-Strategic-and-Potential-Strategic-Partners-and-Other-Interested-Parties.html

19 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/19/3191081/0/en/RespireRx-Pharmaceuticals-Inc-Announces-NIH-NINDS-Grant-Award-and-Amended-and-Restated-Patent-License-Agreement.html

18 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/18/3190168/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Commencement-of-Rule-506-c-Private-Placement.html

18 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/18/3190170/0/en/RespireRx-Pharmaceuticals-Inc-Announces-SEC-Order-Making-Findings-and-Revoking-Registration-of-Securities-and-Future-Plans-with-respect-to-its-Common-Stock.html

10 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/10/3023315/0/en/RespireRx-Pharmaceuticals-Inc-CFO-and-CEO-Issue-Letter-to-Stockholders-Stakeholders-Strategic-and-Potential-Strategic-Partners-and-Other-Interested-Parties.html

29 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/29/2889855/0/en/RespireRx-Pharmaceuticals-Inc-Announces-a-Department-of-Defense-Award-to-Fund-a-Phase-2-Clinical-Study-to-Determine-the-Safety-and-Efficacy-of-CX1739-its-Lead-AMPAkine-to-Improve-B.html
ABOUT THIS PAGE
RespireRx Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of AMPALEX, BULK PHARMACEUTICAL CHEMICAL (BPC) bulk offered by RespireRx Pharmaceuticals